Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS)
CNY 12.03
(0.17%)
CNY 12.03
(0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 11.93 Billion | 12.95 Billion | 13.94 Billion | 12.55 Billion | 12.19 Billion | 11.32 Billion |
| Cost of Revenue | 7.53 Billion | 8.02 Billion | 7.84 Billion | 6.64 Billion | 6.13 Billion | 5.79 Billion |
| Gross Profit | 4.39 Billion | 4.93 Billion | 6.09 Billion | 5.91 Billion | 6.06 Billion | 5.52 Billion |
| Operating Expenses | 3.54 Billion | 3.98 Billion | 4.87 Billion | 4.62 Billion | 4.8 Billion | 4.44 Billion |
| Selling, General and Administrative Expenses | 2.78 Billion | 2.87 Billion | 3.63 Billion | 3.5 Billion | 3.72 Billion | 3.36 Billion |
| Research and Development Expenses | 586 Million | 520.92 Million | 589.18 Million | 498.92 Million | 417.16 Million | 373.64 Million |
| Other Expenses | -22.98 Million | 593.9 Million | 654.62 Million | 619.98 Million | 672.16 Million | 34.11 Million |
| Cost and Expenses | 10.98 Billion | 12.01 Billion | 12.72 Billion | 11.27 Billion | 10.94 Billion | 10.23 Billion |
| Operating Income | 1.08 Billion | 966.13 Million | 1.24 Billion | 1.02 Billion | 1.03 Billion | 1.25 Billion |
| Interest Expense | 57.88 Million | 107.31 Million | 110.46 Million | 123.51 Million | 189.43 Million | 215.65 Million |
| Income Tax Expense | 131.94 Million | 116.63 Million | 97.06 Million | 141.07 Million | 144.38 Million | 223.95 Million |
| Earnings before Tax | 1.09 Billion | 984.11 Million | 918.2 Million | 1.04 Billion | 1.07 Billion | 1.29 Billion |
| Net Income | 691.88 Million | 867.48 Million | 821.14 Million | 900.04 Million | 928.46 Million | 705.52 Million |
| Earnings Per Share Basic | 0.54 | 0.84 | 0.80 | 0.88 | 0.90 | 0.65 |
| Earnings Per Share Diluted | 0.54 | 0.75 | 0.70 | 0.76 | 0.81 | 0.65 |
| Weighted Average Shares Outstanding | 1.27 Billion | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.02 Billion | 1.09 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Billion | 1.15 Billion | 1.17 Billion | 1.17 Billion | 1.15 Billion | 1.09 Billion |
| Gross Margin | 0.37 | 0.38 | 0.44 | 0.47 | 0.50 | 0.49 |
| EBIT Margin | 0.17 | 0.15 | 0.15 | 0.16 | 0.17 | 0.21 |
| Profit Margin | 0.06 | 0.07 | 0.06 | 0.07 | 0.08 | 0.06 |
| EBITDA | 1.97 Billion | 1.93 Billion | 1.84 Billion | 1.89 Billion | 1.98 Billion | 2.22 Billion |
| Earnings Before Tax Margin | 0.09 | 0.07 | 0.09 | 0.08 | 0.08 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.63 Billion | 2.8 Billion | 3.12 Billion | 2.86 Billion | 11.93 Billion | 2.71 Billion |
| Cost of Revenue | 1.58 Billion | 1.79 Billion | 1.84 Billion | 1.88 Billion | 7.62 Billion | 1.67 Billion |
| Gross Profit | 1.04 Billion | 1.01 Billion | 1.27 Billion | 977.26 Million | 4.3 Billion | 1.03 Billion |
| Operating Expenses | 615.72 Million | 541.26 Million | 764.28 Million | 853.69 Million | 3.35 Billion | 756.53 Million |
| Selling, General and Administrative Expenses | 894.53 Million | 422.59 Million | 637.75 Million | 647.1 Million | - | 908.84 Million |
| Research and Development Expenses | 171.6 Million | 110.6 Million | 121.6 Million | 178.73 Million | - | 133.3 Million |
| Other Expenses | -450.41 Million | -8.05 Million | -16.59 Million | -27.86 Million | -56.57 Million | 3.68 Million |
| Cost and Expenses | 2.2 Billion | 2.33 Billion | 2.61 Billion | 2.74 Billion | 10.97 Billion | 2.43 Billion |
| Operating Income | 371.66 Million | 474.99 Million | 524.6 Million | 123.56 Million | 956.24 Million | 308.22 Million |
| Interest Expense | 9.13 Million | 9.22 Million | 9.47 Million | 9.82 Million | 57.88 Million | 10.3 Million |
| Income Tax Expense | 57.72 Million | 117.36 Million | 82.14 Million | 3.83 Million | 131.94 Million | 25.07 Million |
| Earnings before Tax | 370.28 Million | 571.99 Million | 508 Million | 159.18 Million | 1.09 Billion | 308.05 Million |
| Net Income | 236.04 Million | 387.22 Million | 331.25 Million | 127.95 Million | 691.88 Million | 218.98 Million |
| Earnings Per Share Basic | 0.18 | 0.29 | 0.25 | 0.09 | - | 0.16 |
| Earnings Per Share Diluted | 0.18 | 0.29 | 0.25 | 0.09 | - | 0.16 |
| Weighted Average Shares Outstanding | 1.34 Billion | 1.34 Billion | 1.34 Billion | 1.38 Billion | 1.27 Billion | 1.32 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.34 Billion | 1.34 Billion | 1.34 Billion | 1.38 Billion | 1.27 Billion | 1.32 Billion |
| Gross Margin | 0.40 | 0.36 | 0.41 | 0.34 | 0.36 | 0.38 |
| EBIT Margin | 0.14 | 0.24 | 0.17 | 0.12 | - | 0.12 |
| Profit Margin | 0.09 | 0.14 | 0.11 | 0.04 | 0.06 | 0.08 |
| EBITDA | 379.42 Million | 669.5 Million | 525.68 Million | 338.85 Million | - | 328.55 Million |
| Earnings Before Tax Margin | 0.14 | 0.17 | 0.17 | 0.04 | 0.08 | 0.11 |
DNTUY
VYBE
IES
088260
ENGN
CTYLF